Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 460
Filtrar
1.
Gene ; 809: 146004, 2022 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-34648918

RESUMO

Recognition of invading foreign exogenous pathogen is the first step to initiate the innate immune response of insects, which accomplished by the pattern recognition receptors (PRRs). Peptidoglycan recognition proteins (PGRPs) serve as an important type of PRRs, which activate immune response by detecting peptidoglycan of microbial cell wall. In this study, we have cloned the full-length cDNA of PGRP gene called PGRP-S1 from the Diaphania pyloalis (Walker). The open reading frame (ORF) of D. pyloalis PGRP-S1 encodes 211 amino acids which containing a secretion signal peptide and a canonical PGRP domain. Multisequence alignment revealed that PGRP-S1 possess the amino acid residues responsible for zinc binding and amidase activity. D. pyloalis PGRP-S1 exhibited the highest transcript level in fat body and followed in head. The mRNA concentration dramatically increased after an injection of Escherichia coli or Micrococcus luteus. Purified recombinant PGRP-S1 exhibit binding ability to peptidoglycans from Staphylococcus aureus or Bacillus subtilis and cause intensive agglutination of E. coli, M. luteus or S. aureus in the presence of zinc ions. Furthermore, phenoloxidase activity significantly increased when the plasma from larvae was incubated with recombinant PGPR-S1 and peptidoglycans from B. subtilis or M. luteus simultaneously. These results implied that PGRP-S1 was a member involving the prophenoloxidase activation pathway. Overall, our results indicated that D. pyloalis PGRP-S1 serve as a PRR to participate in the recognition of foreign pathogen and prophenoloxidase pathway stimulation.


Assuntos
Proteínas de Transporte/metabolismo , Catecol Oxidase/metabolismo , Precursores Enzimáticos/metabolismo , Proteínas de Insetos/metabolismo , Mariposas/metabolismo , Peptidoglicano/metabolismo , Aglutinação/efeitos dos fármacos , Animais , Bacillus subtilis/química , Proteínas de Transporte/química , Proteínas de Transporte/genética , Parede Celular/metabolismo , Regulação da Expressão Gênica , Proteínas de Insetos/química , Proteínas de Insetos/genética , Lipopolissacarídeos/metabolismo , Mariposas/genética , Mariposas/microbiologia , Filogenia , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia , Staphylococcus aureus/química
2.
Nat Nanotechnol ; 17(1): 86-97, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34795440

RESUMO

This study shows that the supramolecular arrangement of proteins in nanoparticle structures predicts nanoparticle accumulation in neutrophils in acute lung inflammation (ALI). We observed homing to inflamed lungs for a variety of nanoparticles with agglutinated protein (NAPs), defined by arrangement of protein in or on the nanoparticles via hydrophobic interactions, crosslinking and electrostatic interactions. Nanoparticles with symmetric protein arrangement (for example, viral capsids) had no selectivity for inflamed lungs. Flow cytometry and immunohistochemistry showed NAPs have tropism for pulmonary neutrophils. Protein-conjugated liposomes were engineered to recapitulate NAP tropism for pulmonary neutrophils. NAP uptake in neutrophils was shown to depend on complement opsonization. We demonstrate diagnostic imaging of ALI with NAPs; show NAP tropism for inflamed human donor lungs; and show that NAPs can remediate pulmonary oedema in ALI. This work demonstrates that structure-dependent tropism for neutrophils drives NAPs to inflamed lungs and shows NAPs can detect and treat ALI.


Assuntos
Inflamação/patologia , Pulmão/patologia , Nanopartículas/química , Neutrófilos/patologia , Proteínas/química , Doença Aguda , Aglutinação/efeitos dos fármacos , Animais , Anticorpos/farmacologia , Reagentes de Ligações Cruzadas/química , Dextranos/química , Humanos , Lipopolissacarídeos , Lipossomos , Pulmão/diagnóstico por imagem , Masculino , Camundongos Endogâmicos C57BL , Muramidase/metabolismo , Neutrófilos/efeitos dos fármacos , Proteínas Opsonizantes/metabolismo , Eletricidade Estática , Distribuição Tecidual/efeitos dos fármacos , Tomografia Computadorizada de Emissão de Fóton Único , Tomografia Computadorizada por Raios X
3.
Mol Immunol ; 140: 77-86, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34673374

RESUMO

Calreticulin (Crt) is a highly conserved and multi-functional protein with lectin-like properties and important immunological activities. In this study, a Crt homolog, namely, ToCrt, was cloned and characterized from the obscure puffer Takifugu obscurus with an open reading frame of 1278 bp encoding a putative protein of 425 amino acids. The deduced amino acid sequence of ToCrt consisted of three conserved structural domains: N-domain, P-domain, and C-terminal domain. In the phylogenetic tree, ToCrt formed a separate cluster with three Crts from other pufferfish species (Takifugu rubripes, Takifugu flavidus, and Takifugu bimaculatus). The mRNA transcript of ToCrt was ubiquitously expressed in all the examined tissues in a decreasing order: liver, spleen, kidney, gills, intestine, and heart. After Vibrio harveyi, Edwardsiella tarda, and Aeromonas hydrophila stimulations, the levels of ToCrt mRNA in the kidney and spleen were significantly upregulated compared with that in the control group. The recombinant calreticulin domain of ToCrt (rToCrt) could bind three Gram-negative bacteria (V. harveyi, E. tarda, and A. hydrophila) and polysaccharides from bacterial cell walls such as lipopolysaccharide and peptidoglycan. Meanwhile, rToCrt could agglutinate different kinds of microorganisms and exhibit antimicrobial activity. These results suggested that T. obscurus ToCrt could serve as an antimicrobial effector in the host immune response against invading microorganisms.


Assuntos
Anti-Infecciosos/imunologia , Calreticulina/metabolismo , Imunidade , Takifugu/imunologia , Aeromonas hydrophila/efeitos dos fármacos , Aglutinação/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Anti-Infecciosos/farmacologia , Sequência de Bases , Calreticulina/química , Calreticulina/genética , Calreticulina/isolamento & purificação , Edwardsiella tarda/efeitos dos fármacos , Perfilação da Expressão Gênica , Regulação da Expressão Gênica/efeitos dos fármacos , Filogenia , Polissacarídeos/metabolismo , Ligação Proteica/efeitos dos fármacos , Domínios Proteicos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Takifugu/microbiologia , Fatores de Tempo , Vibrio/efeitos dos fármacos
4.
Int J Biol Macromol ; 166: 1173-1187, 2021 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-33159939

RESUMO

In the present study aimed to purify the lectin from the sap of Musa acuminata pseudostem and elucidate the apoptotic and angiogenic molecular mechanism in both in-vitro and in-vivo model. Mannose specific lectin was purified by using mannose affinity column chromatography and analyzed by RP-HPLC, SDS-PAGE, and PAS staining method. Furthermore, the protein was identified by MALDI-MS/MS. MAL effectively agglutinates trypsinized RBCs and showed effective cytotoxicity against various human cancer cell lines. MAL mitigates the cell proliferation, colony formation, cell migration, arrest the cell cycle in the G2/M phase, and induce apoptosis by altering the expression of apoptotic proteins/mRNA level (Bax and Bcl-2) via caspase 8/9, 3 dependent pathway in both in-vitro and in-vivo. Supporting this, in-vivo EAC tumor mice models prove the efficacy of MAL by inducing cell death and inhibiting the neovessel formation by targeting the MVD, inhibition of VEGF secretion, suppressing the expression of MMPs, HIF-1α, Flt-1, Akt, Jnk, and Erk1/2. More importantly, the MAL treatment leads to effective inhibition of tumor growth and an increase in the survivability of EAC mice. Our study summarizes that the MAL having a significant anticancer potential expressively degenerates the tumor development by inducing apoptosis and suppressing neoangiogenesis.


Assuntos
Antineoplásicos Fitogênicos/uso terapêutico , Carcinoma de Ehrlich/patologia , Caspases/metabolismo , Lectinas/uso terapêutico , Sistema de Sinalização das MAP Quinases , Musa/química , Neovascularização Patológica/tratamento farmacológico , Proteínas Proto-Oncogênicas c-akt/metabolismo , Aglutinação/efeitos dos fármacos , Animais , Antineoplásicos Fitogênicos/farmacologia , Apoptose/efeitos dos fármacos , Células Sanguíneas/efeitos dos fármacos , Células Sanguíneas/metabolismo , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Galinhas , Membrana Corioalantoide/efeitos dos fármacos , Membrana Corioalantoide/metabolismo , Modelos Animais de Doenças , Ativação Enzimática/efeitos dos fármacos , Feminino , Células HeLa , Humanos , Lectinas/isolamento & purificação , Lectinas/farmacologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Camundongos Endogâmicos BALB C , Proteínas de Neoplasias/metabolismo , Fosforilação/efeitos dos fármacos , Testes de Toxicidade Aguda
5.
Fish Shellfish Immunol ; 106: 776-782, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32745619

RESUMO

Penaeid prawns are considered as most demanding fishery resources. The current study aims to purify and characterize lectin from the haemolymph of Penaeus semisulcatus. The semisulcatus-lectin was purified by affinity chromatography using mannose coupled Sepharose CL-4B column and purified lectin exhibited a single band of 66 kDa in SDS-PAGE. The purity and crystalline structure of purified lectin was confirmed by HPLC and X-ray diffraction analysis. Semisulcatus-lectin exhibited yeast agglutination activity against Saccharomyces cerevisiae and agglutinated human erythrocytes. Semisulcatus-lectin was evaluated for phenol oxidase activation and phagocytic activities. It was observed that semisulcatus-lectin had antibacterial activity against Gram-negative Vibrio parahaemolyticus and Aeromonas hydrophila, suggesting a potential therapeutic strategy in aquaculture industry for disease management.


Assuntos
Antibacterianos/farmacologia , Proteínas de Artrópodes/farmacologia , Lectinas/farmacologia , Penaeidae , Aeromonas hydrophila/efeitos dos fármacos , Aeromonas hydrophila/fisiologia , Aglutinação/efeitos dos fármacos , Animais , Antibacterianos/isolamento & purificação , Proteínas de Artrópodes/isolamento & purificação , Biofilmes/efeitos dos fármacos , Eritrócitos/efeitos dos fármacos , Hemolinfa/química , Humanos , Lectinas/isolamento & purificação , Monofenol Mono-Oxigenase/metabolismo , Saccharomyces cerevisiae/efeitos dos fármacos , Vibrio parahaemolyticus/efeitos dos fármacos , Vibrio parahaemolyticus/fisiologia
6.
Chemistry ; 26(5): 1037-1041, 2020 Jan 22.
Artigo em Inglês | MEDLINE | ID: mdl-31749263

RESUMO

High aspect ratio, sugar-decorated 2D nanosheets are ideal candidates for the capture and agglutination of bacteria. Herein, the design and synthesis of two carbohydrate-based Janus amphiphiles that spontaneously self-assemble into high aspect ratio 2D sheets are reported. The unique structural features of the sheets include the extremely high aspect ratio and dense display of galactose on the surface. These structural characteristics allow the sheet to act as a supramolecular 2D platform for the capture and agglutination of E. coli through specific multivalent noncovalent interactions, which significantly reduces the mobility of the bacteria and leads to the inhibition of their proliferation. Our results suggest that the design strategy demonstrated here can be applied as a general approach for the crafting of biomolecule-decorated 2D nanosheets, which can perform as 2D platforms for their interaction with specific targets.


Assuntos
Dendrímeros/metabolismo , Escherichia coli/metabolismo , Galactose/química , Nanoestruturas/química , Aglutinação/efeitos dos fármacos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Dendrímeros/química , Humanos , Nanopartículas Metálicas/química , Microscopia de Força Atômica , Nanoestruturas/toxicidade , Prata/química
7.
PLoS One ; 14(7): e0220318, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31344098

RESUMO

Lectins are a group of ubiquitous proteins which specifically recognize and reversibly bind sugar moieties of glycoprotein and glycolipid constituents on cell surfaces. The mutagenesis approach is often employed to characterize lectin binding properties. As lectins are not enzymes, it is not easy to perform a rapid specificity screening of mutants using chromogenic substrates. It is necessary to use different binding assays such as isothermal titration calorimetry (ITC), surface plasmon resonance (SPR), microscale thermophoresis (MST), enzyme-linked lectin assays (ELLA), or glycan arrays for their characterization. These methods often require fluorescently labeled proteins (MST), highly purified proteins (SPR) or high protein concentrations (ITC). Mutant proteins may often exhibit problematic behaviour, such as poor solubility or low stability. Lectin-based cell agglutination is a simple and low-cost technique which can overcome most of these problems. In this work, a modified method of the agglutination of human erythrocytes and yeast cells with microscopy detection was successfully used for a specificity study of the newly prepared mutant lectin RS-IIL_A22S, which experimentally completed studies on sugar preferences of lectins in the PA-IIL family. Results showed that the sensitivity of this method is comparable with ITC, is able to determine subtle differences in lectin specificity, and works directly in cell lysates. The agglutination method with microscopy detection was validated by comparison of the results with results obtained by agglutination assay in standard 96-well microtiter plate format. In contrast to this assay, the microscopic method can clearly distinguish between hemagglutination and hemolysis. Therefore, this method is suitable for examination of lectins with known hemolytic activity as well as mutant or uncharacterized lectins, which could damage red blood cells. This is due to the experimental arrangement, which includes very short sample incubation time in combination with microscopic detection of agglutinates, that are easily observed by a small portable microscope.


Assuntos
Testes de Aglutinação , Proteínas de Bactérias/farmacologia , Eritrócitos/efeitos dos fármacos , Lectinas/farmacologia , Leveduras/efeitos dos fármacos , Aglutinação/efeitos dos fármacos , Testes de Aglutinação/métodos , Eritrócitos/citologia , Proteínas de Escherichia coli/farmacologia , Hemaglutinação/efeitos dos fármacos , Hemólise/efeitos dos fármacos , Humanos , Microscopia , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/efeitos dos fármacos , Ressonância de Plasmônio de Superfície , Leveduras/citologia
8.
In Vitro Cell Dev Biol Anim ; 55(6): 405-415, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31140104

RESUMO

Lactadherin is an extracellular matrix glycoprotein with stimulating agglutination ability that plays crucial roles in animal immunology. In the present study, a novel lactadherin, Sc-lactadherin, was identified from the marine invertebrate chordate, Styela clava. Its full-length cDNA consisted of 579 bps, encoding 193 amino acids with a coagulation FA58C domain. Recombinant Sc-lactadherin via a prokaryotic expression system showed strong hemocyte fusion activity. Therefore, we further examined its effects on cell behaviors using human umbilical vein endothelial cells (HUVECs) and human cervical cancer (HeLa) cells. Recombinant Sc-lactadherin significantly increased the proliferation rate of HUVECs and HeLa cells and improved the cell migration rate of HUVECs. These results demonstrated that the lactadherin identified from the marine ascidian displayed the agglutinating activity. Functional characterization of the recombinant protein showed that it promoted cell proliferation and migration, indicating the potential roles of Sc-lactadherin in immunology and organogenesis in marine ascidians.


Assuntos
Aglutinação/efeitos dos fármacos , Glicoproteínas/genética , Glicoproteínas/farmacologia , Urocordados/genética , Animais , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Clonagem Molecular , Glicoproteínas/isolamento & purificação , Glicoproteínas/metabolismo , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Células HeLa , Hemócitos/fisiologia , Células Endoteliais da Veia Umbilical Humana , Humanos , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia
9.
Mar Drugs ; 17(2)2019 Feb 25.
Artigo em Inglês | MEDLINE | ID: mdl-30823584

RESUMO

We identified a lectin (carbohydrate-binding protein) belonging to the complement 1q(C1q) family in the feather star Anneissia japonica (a crinoid pertaining to the phylum Echinodermata). The combination of Edman degradation and bioinformatics sequence analysis characterized the primary structure of this novel lectin, named OXYL, as a secreted 158 amino acid-long globular head (sgh)C1q domain containing (C1qDC) protein. Comparative genomics analyses revealed that OXYL pertains to a family of intronless genes found with several paralogous copies in different crinoid species. Immunohistochemistry assays identified the tissues surrounding coelomic cavities and the arms as the main sites of production of OXYL. Glycan array confirmed that this lectin could quantitatively bind to type-2 N-acetyllactosamine (LacNAc: Galß1-4GlcNAc), but not to type-1 LacNAc (Galß1-3GlcNAc). Although OXYL displayed agglutinating activity towards Pseudomonas aeruginosa, it had no effect on bacterial growth. On the other hand, it showed a significant anti-biofilm activity. We provide evidence that OXYL can adhere to the surface of human cancer cell lines BT-474, MCF-7, and T47D, with no cytotoxic effect. In BT-474 cells, OXYL led to a moderate activation of the p38 kinase in the MAPK signaling pathway, without affecting the activity of caspase-3. Bacterial agglutination, anti-biofilm activity, cell adhesion, and p38 activation were all suppressed by co-presence of LacNAc. This is the first report on a type-2 LacNAc-specific lectin characterized by a C1q structural fold.


Assuntos
Equinodermos/química , Lectinas/farmacologia , Aglutinação/efeitos dos fármacos , Sequência de Aminoácidos , Amino Açúcares/química , Amino Açúcares/metabolismo , Animais , Sequência de Bases , Biofilmes/efeitos dos fármacos , Caspase 3/metabolismo , Linhagem Celular Tumoral , Humanos , Lectinas/química , Lectinas/genética , Lectinas/metabolismo , Ligação Proteica , Pseudomonas aeruginosa/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
10.
J Fish Dis ; 42(3): 371-377, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30644117

RESUMO

The antimicrobial activity and mode of action of chitosan were evaluated against Streptococcus iniae, a pathogenic Gram-positive bacterium of fish worldwide. Cell proliferation kinetics were examined following exposure to varying concentrations of chitosan. The action of chitosan on S. iniae was also investigated by measuring agglutination activity, conductivity, and extracellular and intracellular bacterial adenosine triphosphate (ATP) levels. Chitosan exhibited antibacterial activity against S. iniae at concentrations of 0.1% and above and was lethal at a concentration of 0.4% and higher. The mechanism of antibacterial activity of chitosan at the inhibitory level of bacterial growth appears to hinge upon the interaction between chitosan and the oppositely charged bacterial surface. This interplay causes agglutination, which was readily observed grossly and microscopically. After interacting with the cell surface via adsorption, an efflux of intracellular ATP was documented, which suggests that chitosan disrupts the bacterial cell causing leakage of cytosolic contents and ultimately cell death. Results suggest chitosan may be worth evaluating as a natural alternative to antibiotic against S. iniae infection of fish.


Assuntos
Anti-Infecciosos/farmacologia , Quitosana/farmacologia , Streptococcus iniae/efeitos dos fármacos , Trifosfato de Adenosina/análise , Aglutinação/efeitos dos fármacos , Permeabilidade da Membrana Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Streptococcus iniae/citologia
11.
Carbohydr Res ; 469: 60-72, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30296643

RESUMO

As a part of ongoing activities towards the design of ligands against pathogenic lectins, a synthesis of original α-C-galacto/α-C-manno/α-C-fucopyranosyl glycomimetics based on a calix[4]arene scaffold and their binding evaluation is described. The interactions of the glycomimetics with seven lectins of various origins were carried out using agglutination inhibition assays. The 1,3-alternate tetra-C-fucosylated ligand and its derivative having a tertBu group at the upper rim of the calix[4]arene scaffold were the most potent towards the AAL lectin family (RSL, AFL, AAL, AOL) and BC2L-C. As AFL and RSL originate from important human (Aspergillus fumigatus) and plant (Ralstonia solanacearum) pathogens, the inhibition potency of both leading structures was assessed by surface plasmon resonance. With AFL, both structures exhibited an approximately three orders of magnitude increase in affinity compared to the reference l-fucose. The role of tertBu groups as "aglycon-assisted" events was illustrated by NMR. Furthermore, both compounds showed significantly increased ability to inhibit BC2L-C (from human pathogen Burkholderia cenocepacia) cell agglutination and were able to cross-link whole B. cenocepacia cells. Although the ligands failed to significantly inhibit the agglutination activity of LecA and LecB from Pseudomonas aeruginosa, tetra-C-galactosylated calix[4]arene with tertBu groups at the upper rim of the 1,3-alternate conformation inhibited P. aeruginosa biofilm formation efficiently. This systematic and comprehensive study highlights the fact that hydrolytically stable polyvalent C-glycomimetics should be regarded as potent and selective ligands capable of acting as antiadhesive agents.


Assuntos
Materiais Biomiméticos/química , Calixarenos/química , Lectinas/química , Aglutinação/efeitos dos fármacos , Biofilmes/efeitos dos fármacos , Materiais Biomiméticos/farmacologia , Calixarenos/farmacologia , Humanos , Ligantes , Modelos Moleculares , Conformação Molecular , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/fisiologia
12.
Pak J Pharm Sci ; 31(3(Supplementary)): 1013-1020, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29731438

RESUMO

Lectin has attracted attention because of its ability to serve as a carrier for targeted drug delivery. Large lectins isolated from marine invertebrates and crustaceans have strong immunogenicity and adverse effects, which limit their usefulness. This study reports the identification of catesbeianalectin via screening a bullfrog skin cDNA library. The catesbeianalectin polypeptide has a molecular weight of 1.47 kD, making it the smallest known lectin in terms of molecular weight. Circular dichroism analysis showed a PPII helix secondary structure. Catesbeianalectin strongly induces agglutination of rabbit erythrocytes and a variety of pathogens include Staphylococcus aureus, Streptococcus suis type 2, Actinobacillus pleuropneumoniae, and piglet paratyphoid Salmonella. The mean serum titer in catesbeianalectin-immunized Balb/c mice was 1:25, which was significantly lower than that of positive controls immunized with wheat germ agglutinin. Surface plasmon resonance indicated an S-type lectin. 125I-labeled catesbeianalectin did not pass the blood-brain barrier. This study provides a basis for further research on the potential of catesbeianalectin as a carrier in targeted drug delivery.


Assuntos
Aglutinação/efeitos dos fármacos , Lectinas/metabolismo , Animais , Bactérias/imunologia , Eritrócitos/imunologia , Feminino , Radioisótopos do Iodo/química , Camundongos , Coelhos , Distribuição Tecidual
13.
Appl Microbiol Biotechnol ; 102(13): 5483-5494, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29705959

RESUMO

Fungal immunomodulatory proteins (FIPs) have been identified from a series of fungi, especially in Ganoderma species. However, little is known about the FIPs from G. applanatum. In this study, two novel FIP genes, termed as FIP-gap1 and FIP-gap2, were cloned from G. applanatum, characterized and functionally expressed after codon optimization in Pichia pastoris GS115. Results showed that FIP-gap1 and FIP-gap2 comprised 342-bp encoding peptides of 113 amino acids, which shared a high homology with other Ganoderma FIPs. The yield of recombinant FIP-gap1 and FIP-gap2 increased significantly after codon optimization and reached 247.4 and 197.5 mg/L, respectively. Bioactivity assay in vitro revealed that both rFIP-gap1 and rFIP-gap2 could agglutinate mouse, sheep, and human red blood cells. Besides, rFIP-gap1 and rFIP-gap2 obviously stimulated the proliferation of mouse splenocytes and enhanced IL-2 and IFN-γ release. Cytotoxicity detection indicated that IC50 of rFIP-gap1 towards A549 and HeLa cancer cells were 29.89 and 8.34 µg/mL, respectively, whereas IC50 of rFIP-gap2 to the same cancer cells were 60.92 and 41.05 µg/mL, respectively. Taken together, novel FIP gaps were cloned and functionally expressed in P. pastoris, which can serve as feasible and stable resources of rFIP gaps for further studies and potential applications.


Assuntos
Códon/genética , Ganoderma/genética , Regulação Fúngica da Expressão Gênica/genética , Pichia/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacologia , Células A549 , Aglutinação/efeitos dos fármacos , Animais , Sobrevivência Celular/efeitos dos fármacos , Clonagem Molecular , Eritrócitos/efeitos dos fármacos , Proteínas Fúngicas/genética , Proteínas Fúngicas/farmacologia , Proteínas Fúngicas/toxicidade , Células HeLa , Humanos , Fatores Imunológicos/genética , Fatores Imunológicos/farmacologia , Fatores Imunológicos/toxicidade , Camundongos , Proteínas Recombinantes/toxicidade
14.
J Clin Pharm Ther ; 43(5): 675-681, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29679392

RESUMO

WHAT IS KNOWN AND OBJECTIVE: For analysis of blood concentrations of everolimus, many hospital laboratories use either latex agglutination turbidimetric immunoassay (LTIA) or electrochemiluminescence immunoassay (ECLIA). However, no studies have compared both immunoassay methods under the same conditions. Accordingly, in this study, we compared everolimus blood concentrations obtained by LTIA and ECLIA in renal transplant patients. METHODS: Blood samples (n = 230) from 60 renal transplant patients (19 female and 41 male) were evaluated using both immunoassays. Subsequently, we switched the assay for detection of everolimus blood concentrations from LTIA to ECLIA as a clinical application. Three quality control (QC) samples for LTIA were analysed using ECLIA, and 3 QC samples for ECLIA were analysed using LTIA. RESULTS: The Deming regression of ECLIA versus LTIA generated the following parameters: slope, 1.0067 and intercept, 1.7489 ng/mL, in the analysis of 230 samples. Bland-Altman analysis showed an average positive bias of 1.73 ng/mL between ECLIA and LTIA. When the clinical apparatus was switched from LTIA to ECLIA, the average everolimus blood concentration assayed by LTIA before switching was 3.57 ng/mL, whereas that by ECLIA after switching in the same patients taking the same daily dose (mean: 1.43 mg/day) was 5.85 ng/mL. The QCs assayed using LTIA were lower by an average of 67.3% (range: 55.8%-79.5%) for ECLIA, and in the same 230 samples from patients, the everolimus blood concentrations assayed by LTIA were lower by an average of 67.4% (range: 37.1%-114.5%) of ECLIA. WHAT IS NEW AND CONCLUSION: Analysis of everolimus concentrations by immunoassays with high precision and accuracy is required to ensure long-term survival of transplant recipients. Although the concentrations of QCs and calibrators of everolimus in LTIA were previously corrected to 70% concentration because of cross-reactivity with everolimus metabolites, these adjustments may need to be reviewed.


Assuntos
Aglutinação/efeitos dos fármacos , Everolimo/sangue , Imunoensaio/métodos , Imunossupressores/sangue , Imunoturbidimetria/métodos , Látex/imunologia , Testes Diagnósticos de Rotina/métodos , Monitoramento de Medicamentos/métodos , Feminino , Humanos , Transplante de Rim/métodos , Masculino , Pessoa de Meia-Idade
15.
Sci Rep ; 7(1): 17795, 2017 12 19.
Artigo em Inglês | MEDLINE | ID: mdl-29259246

RESUMO

Host defense cationic Antimicrobial Peptides (AMPs) can kill microorganisms including bacteria, viruses and fungi using various modes of action. The negatively charged bacterial membranes serve as a key target for many AMPs. Bacterial cell death by membrane permeabilization has been well perceived. A number of cationic AMPs kill bacteria by cell agglutination which is a distinctly different mode of action compared to membrane pore formation. However, mechanism of cell agglutinating AMPs is poorly understood. The outer membrane lipopolysaccharide (LPS) or the cell-wall peptidoglycans are targeted by AMPs as a key step in agglutination process. Here, we report the first atomic-resolution structure of thanatin, a cell agglutinating AMP, in complex with LPS micelle by solution NMR. The structure of thanatin in complex with LPS, revealed four stranded antiparallel ß-sheet in a 'head-tail' dimeric topology. By contrast, thanatin in free solution assumed an antiparallel ß-hairpin conformation. Dimeric structure of thanatin displayed higher hydrophobicity and cationicity with sites of LPS interactions. MD simulations and biophysical interactions analyses provided mode of LPS recognition and perturbation of LPS micelle structures. Mechanistic insights of bacterial cell agglutination obtained in this study can be utilized to develop antibiotics of alternative mode of action.


Assuntos
Aglutinação/efeitos dos fármacos , Peptídeos Catiônicos Antimicrobianos/farmacologia , Bactérias/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Antibacterianos/farmacologia , Membrana Celular/efeitos dos fármacos , Parede Celular/efeitos dos fármacos , Interações Hidrofóbicas e Hidrofílicas/efeitos dos fármacos , Micelas
16.
Med Mol Morphol ; 50(2): 103-111, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28283804

RESUMO

It remains unclear why gastric disease does not develop in all cases of Helicobacter pylori infection. In this study, we analyzed whether simian virus 5 (SV5) enhanced adherence of H. pylori to adenocarcinoma epithelial cells (AGS). H. pylori in AGS (harboring SV5) and SV5-infected Vero cells, and an agglutination of H. pylori mixed with SV5 were observed by light microscopy, scanning and transmission electron microscopies. The adherent rate of H. pylori to SV5-infected Vero cells and treated with an anti-SV5 antibody was determined. H. pylori adhered to the surface of AGS cells near SV5 particles, as shown by scanning and transmission electron microscopies. The adherence of H. pylori to SV5-infected Vero cells was significantly enhanced compared with that to Vero cells. In contrast, the adherence of H. pylori to Vero cells was decreased by treatment with the anti-SV5 antibody. Agglutination of H. pylori mixed with SV5 was observed by scanning and transmission electron microscopies. Agglutination did not occur when SV5 was treated with the anti-SV5 antibody before mixing. These findings demonstrated that SV5 enhanced the adherence of H. pylori to host cells, suggesting that a persistently infected virus may be a factor enhancing the pathogenicity of H. pylori in humans.


Assuntos
Anticorpos Neutralizantes/farmacologia , Anticorpos Antivirais/farmacologia , Células Epiteliais/efeitos dos fármacos , Helicobacter pylori/efeitos dos fármacos , Interações Microbianas , Vírus da Parainfluenza 5/efeitos dos fármacos , Aglutinação/efeitos dos fármacos , Animais , Aderência Bacteriana/efeitos dos fármacos , Linhagem Celular Tumoral , Chlorocebus aethiops , Células Epiteliais/microbiologia , Células Epiteliais/ultraestrutura , Células Epiteliais/virologia , Helicobacter pylori/crescimento & desenvolvimento , Helicobacter pylori/patogenicidade , Helicobacter pylori/ultraestrutura , Humanos , Vírus da Parainfluenza 5/crescimento & desenvolvimento , Células Vero
17.
J Agric Food Chem ; 65(4): 777-783, 2017 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-28051864

RESUMO

Ovomucin is a glycoprotein from egg white with potential to act as an anti-adhesive agent against infectious diseases. This study aimed to determine whether ovomucin or ovomucin hydrolysates could prevent adhesion of two porcine K88 enterotoxigenic Escherichia coli (ETEC) strains. Adhesion was assessed in vitro using a hemagglutination assay. Ovomucin hydrolysates, but not intact ovomucin, prevented adhesion of ETEC to porcine erythrocytes. The ovomucin hydrolysate prepared by acid protease II exhibited the best anti-agglutinating activity against both strains; this hydrolysate was fractionated by cation exchange chromatography and reverse-phase high-performance liquid chromatography (HPLC). The most active fractions, F3(9) and F7(1), with minimal inhibitory concentrations of 0.03 and 0.25 g/L against strains ECL13795 and ECL13998, respectively, were subjected to structural characterization. Six identified glycopeptides were all derived from α-ovomucin, composed of a pentasaccharide core of two N-acetylglucosamine and three mannose residues (GlcNAc2Man3) and a bisecting N-acetylglucosamine (GlcNAc). The terminal ß-linked galactose from these glycopeptides could be one of the binding sites for K88ac fimbriae.


Assuntos
Aderência Bacteriana/efeitos dos fármacos , Escherichia coli Enterotoxigênica/efeitos dos fármacos , Infecções por Escherichia coli/tratamento farmacológico , Glicopeptídeos/administração & dosagem , Ovomucina/química , Doenças dos Suínos/tratamento farmacológico , Adesinas de Escherichia coli/genética , Adesinas de Escherichia coli/metabolismo , Aglutinação/efeitos dos fármacos , Animais , Galinhas , Escherichia coli Enterotoxigênica/genética , Escherichia coli Enterotoxigênica/fisiologia , Infecções por Escherichia coli/microbiologia , Proteínas de Escherichia coli , Glicopeptídeos/química , Glicopeptídeos/isolamento & purificação , Mucosa Intestinal/microbiologia , Ovomucina/administração & dosagem , Suínos , Doenças dos Suínos/microbiologia
18.
Antimicrob Agents Chemother ; 60(10): 6313-25, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27527084

RESUMO

Eradication of established biofilm communities of pathogenic Gram-negative species is one of the pending challenges for the development of new antimicrobial agents. In particular, Pseudomonas aeruginosa is one of the main dreaded nosocomial species, with a tendency to form organized microbial communities that offer an enhanced resistance to conventional antibiotics. We describe here an engineered antimicrobial peptide (AMP) which combines bactericidal activity with a high bacterial cell agglutination and lipopolysaccharide (LPS) affinity. The RN3(5-17P22-36) peptide is a 30-mer derived from the eosinophil cationic protein (ECP), a host defense RNase secreted by eosinophils upon infection, with a wide spectrum of antipathogen activity. The protein displays high biofilm eradication activity that is not dependent on its RNase catalytic activity, as evaluated by using an active site-defective mutant. On the other hand, the peptide encompasses both the LPS-binding and aggregation-prone regions from the parental protein, which provide the appropriate structural features for the peptide's attachment to the bacterial exopolysaccharide layer and further improved removal of established biofilms. Moreover, the peptide's high cationicity and amphipathicity promote the cell membrane destabilization action. The results are also compared side by side with other reported AMPs effective against either planktonic and/or biofilm forms of Pseudomonas aeruginosa strain PAO1. The ECP and its derived peptide are unique in combining high bactericidal potency and cell agglutination activity, achieving effective biofilm eradication at a low micromolar range. We conclude that the designed RN3(5-17P22-36) peptide is a promising lead candidate against Gram-negative biofilms.


Assuntos
Antibacterianos/farmacologia , Proteína Catiônica de Eosinófilo/química , Lipopolissacarídeos/metabolismo , Pseudomonas aeruginosa/efeitos dos fármacos , Aglutinação/efeitos dos fármacos , Animais , Antibacterianos/metabolismo , Biofilmes/efeitos dos fármacos , Eritrócitos/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/farmacologia , Plâncton/microbiologia , Pseudomonas aeruginosa/metabolismo , Pseudomonas aeruginosa/fisiologia
19.
Microbiol Immunol ; 60(9): 609-16, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27554301

RESUMO

Human noroviruses (NoVs) are a major cause of epidemic and sporadic acute gastroenteritis worldwide. Public and personal hygiene is one of the most important countermeasures for preventing spread of NoV infection. However, no a practicable cell culture system for NoV had been developed, initial tests of the virucidal effectiveness of anti-NoV disinfectants and sanitizers have been performed using surrogate viruses. In this study, NoV virus-like particles (VLPs) were used as a new surrogate for NoVs and a method for evaluating NoV inactivation using them developed. This method is based on morphological changes in VLPs after treatment with sodium hypochlorite. VLP specimens were found to become deformed and degraded in a concentration-dependent manner. Based on these results, the effects of sodium hypochlorite on VLPs were classified into four phases according to morphological changes and number of particles. Using the criteria thus established, the efficacy of ethanol, carbonates and alkali solutions against VLPs was evaluated. Deformation and aggregation of VLPs were observed after treatment with these disinfectants under specific conditions. To determine the degradation mechanism(s), VLPs were examined by SDS-PAGE and immunoblotting after treatment with sodium hypochlorite and ethanol. The band corresponding to the major capsid protein, VP1, was not detected after treatment with sodium hypochlorite at concentrations greater than 500 ppm, but remained after treatment with ethanol. These results suggest that VLPs have excellent potential as a surrogate marker for NoVs and can be used in initial virucidal effectiveness tests to determine the mechanism(s) of chemical agents on NoVs.


Assuntos
Desinfetantes/farmacologia , Norovirus/efeitos dos fármacos , Ativação Viral/efeitos dos fármacos , Aglutinação/efeitos dos fármacos , Capsídeo/efeitos dos fármacos , Capsídeo/ultraestrutura , Proteínas do Capsídeo/metabolismo , Etanol/farmacologia , Humanos , Norovirus/ultraestrutura , Hipoclorito de Sódio/farmacologia
20.
Int J Med Mushrooms ; 18(1): 67-74, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27279446

RESUMO

Fungal lectins constitute excellent ligands for development of affinity adsorbents useful in affinity chromatography. In this work, a lectin was purified from Pycnoporus sanguineus (PSL) mycelium using 3 procedures: by affinity chromatography, using magnetic galactosyl-nanoparticles or galactose coupled to Sepharose, and by ionic exchange chromatography (IEC). The highest lectin yield was achieved by IEC (55%); SDS-PAGE of PSL showed 2 bands with molecular mass of 68.7 and 55.2 kDa and IEC displayed 2 bands at pi 5.5 and 5.2. The lectin agglutinates rat erythrocytes, exhibiting broad specificity toward several monosaccharides, including galactose. The agglutination was also inhibited by the glycoproteins fetal calf fetuin, bovine lactoferrin, bovine transferrin, and horseradish peroxidase. The lectin was then used to synthesize an affinity adsorbent (PSL-Sepharose) and the interaction with glycoproteins was evaluated by analyzing their chromatographic behaviors. The strongest interaction with the PSL-derivative was observed with transferrin, although lower interactions were also displayed toward fetuin and lactoferrin. These results indicate that the purified PSL constitutes an interesting ligand for the design of affinity adsorbents to be used (i.e., in glycoprotein purification).


Assuntos
Lectinas/isolamento & purificação , Pycnoporus/química , Transferrina/metabolismo , Aglutinação/efeitos dos fármacos , Animais , Bovinos , Cromatografia de Afinidade , Cromatografia por Troca Iônica , Eritrócitos/efeitos dos fármacos , Proteínas Fúngicas/isolamento & purificação , Proteínas Fúngicas/metabolismo , Galactose/metabolismo , Glicoproteínas/isolamento & purificação , Glicoproteínas/metabolismo , Lectinas/metabolismo , Ligantes , Peso Molecular , Micélio/química , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...